NCT06412146

Children's Mercy Teens With Type 1 Diabetes Will Participate in an Online Peer Support Group.

Diabetes Link Discord
Children's Mercy Hospital Kansas City·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Type 1 Diabetes
Drug/Device/Intervention
Peer Support Group
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Children's Mercy Hospital Kansas City
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Sep 30, 2024
Enrollment
20 participants
Primary outcome

Discord User Metrics,Final Feedback Survey

Summary

The goal of this observational study is to examine the impact of an online peer support group
 in Children's Mercy teens with Type 1 Diabetes.
 
 The main objectives are to examine the feasibility and acceptability of the Diabetes Link's
 online social platform Discord among youth with diabetes as it relates to peer support,
 diabetes management, and usability and to examine the efficacy/magnitude of the effect of the
 Discord group on treatment adherence among youth with diabetes.
 
 Participants will participate in an online peer support group for 3 months and provide their
 feedback while doing so.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06412146
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06412146 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Mercy Hospital Kansas City and is currently Not yet recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.